NEW PROGESTOGENS IN ORAL-CONTRACEPTIVES

被引:25
作者
RUNNEBAUM, B
RABE, T
机构
关键词
D O I
10.1016/S0002-9378(87)80132-1
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
引用
收藏
页码:1059 / 1063
页数:5
相关论文
共 12 条
[1]   ORAL-CONTRACEPTIVES, LIPIDS AND CARDIOVASCULAR-DISEASE [J].
FOTHERBY, K .
CONTRACEPTION, 1985, 31 (04) :367-394
[2]  
IRSIGLER K, 1982, AKTUELLE ASPEKTE HOR, P65
[3]  
KOHLMEIER M, 1985, HORMONALE KONTRAZEPT, P58
[4]  
MALL T, 1983, KONTRAZEPTION STANDO, P114
[5]  
PANE IQ, 1984, BR J HAEMATOL, V58, P317
[6]  
RABE T, 1985, HORMONALE KONTRAZEPT, P40
[7]  
SCHIJF CPT, 1983, FERTIL STERIL, P585
[8]   SYNTHETIC PROGESTINS - INVITRO POTENCY ON HUMAN ENDOMETRIUM AND SPECIFIC BINDING TO CYTOSOL RECEPTOR [J].
SHAPIRO, SS ;
DYER, RD ;
COLAS, AE .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1978, 132 (05) :549-554
[9]   THE SHORT-TERM EFFECTS OF A LOW-DOSE ORAL-CONTRACEPTIVE ON GLUCOSE-METABOLISM, PLASMA-LIPIDS AND BLOOD-CLOTTING FACTORS [J].
SKOUBY, SO ;
WAGNER, HH ;
ANDERSEN, O .
CONTRACEPTION, 1983, 28 (05) :489-499
[10]   BIO-AVAILABILITY AND PHARMACOKINETICS OF CYPROTERONE ACETATE-C-14 AND ETHINYLOESTRADIOL-H-3 AFTER ORAL-ADMINISTRATION AS A COATED TABLET (SH B 209 AB) [J].
SPECK, U ;
WENDT, H ;
SCHULZE, PE ;
JENTSCH, D .
CONTRACEPTION, 1976, 14 (02) :151-163